Most Read Articles
6 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Yesterday
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
Roshini Claire Anthony, 5 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

5 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.

Educational intervention, overprescription reduce opioid use after pelvic floor surgery

15 May 2019
The more painful the surgery, the more likely addiction is, according to a report by the research firm QuintilesIMS Institute for Healthcare Informatics

Overprescription of opioids after pelvic floor surgery and a provider education intervention have led to a substantial decrease in opioid prescribing without changing patient satisfaction with pain control, a recent study has found.

In total, 122 patients were prescribed 149 percent more mean morphine mg equivalents than were actually used for sacral neuromodulation, 165 percent more for mid urethral sling and 136 percent more for prolapse repair.

A significant reduction in morphine mg equivalents prescribed for all three surgeries was observed in 78 patients (p<0.001) after the educational intervention. In addition, the following factors were found to be associated with increased opioid use: diabetes (p=0.001), a chronic pain condition (p=0.017) and rectocele repair (p=0.001).

This retrospective review explored prescribing patterns and opioid use in patients who underwent three pelvic floor surgeries (ie, sacral neuromodulation, prolapse repair and mid urethral sling) from June 2016 to May 2017 before and after an educational intervention to reduce opioid prescriptions.

The authors conducted a telephone survey to quantify opioid use after surgery and satisfaction with pain control. They established prescribing recommendations based on these results and performed an educational intervention for clinicians. This was followed by an assessment of changes in opioid prescription and use during the 6 months following the intervention. To identify factors associated with variability in opioid use, a multiple regression model was used.

“The opioid problem has reached epidemic proportions and the prescription of opioids after surgery can lead to chronic use,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Yesterday
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
Roshini Claire Anthony, 5 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

5 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.